| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65f98481c18d0b28361a5745ca4375e8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2020-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13c2e5b81fb41467019c034fb00f4f47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_692fd03148766104f0cfa2292b29ef07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a179c235c7f92d3677910ef90853dbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4c4fb8f77d89d5bc942e4829c9ebf6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aae60229007d25c82157dc4b7923ebfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0321cb11f02489e58edb62f8a7ee4e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7086ef5e3b098a7dc77a79a1c8eb24b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1035049305369ba80ae44c4b8f5c8c1 |
| publicationDate |
2022-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114075198-A |
| titleOfInvention |
A novel astragalus alkaloid and its application in the treatment of neurodegenerative diseases |
| abstract |
The present invention relates to a novel astragalus alkaloid and its application in the treatment of neurodegenerative diseases, wherein the astragalus alkaloid has the structure shown in formula I: In the present invention, the astragalus alkaloids with the structure of formula I are separated from astragalus by yeast fermentation for the first time, which have significantly better nerve-like growth factor (NGF) activity and are expected to be developed as drugs or functional foods with neurotrophic and neuroprotective functions. , for the treatment of neurodegenerative diseases such as Alzheimer's. |
| priorityDate |
2020-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |